Jacqueline Jeruss, M.D., Ph.D.
Associate Professor, Departments of Surgery, Pathology, and Biomedical Engineering
Director, Breast Care Center for the University of Michigan
Director, Breast Surgical Oncology Fellowship
Division of Surgical Oncology
3303 Cancer Center
1500 East Medical Center Drive
Ann Arbor, MI 48109
Dr. Jeruss is an Associate Professor of Surgery and the Director of the University of Michigan Breast Care Center. She also holds appointments in the Departments of Pathology and Biomedical Engineering at the University of Michigan. Dr. Jeruss received her undergraduate degree in neuroscience and history from Brandeis University and her medical degree from the University of Vermont. Dr. Jeruss completed her General Surgery residency training at Northwestern University Medical School and holds a PhD from Northwestern, having done her dissertation in the field of breast cancer biology. She completed her fellowship in Breast Surgical Oncology at M.D. Anderson Cancer Center in 2006, and returned to Northwestern as Associate Professor of Surgery in the Division of Breast Surgery before joining the University of Michigan faculty.
Dr. Jeruss is board certified in General Surgery and is a member of several professional societies. Through her basic and clinical research program, Dr. Jeruss has been actively involved in the training of high school students, undergraduates, graduate students at the PhD and post-doctoral levels, medical students, and residents. She has published numerous manuscripts and book chapters, and has also received many awards for teaching and research.
Dr. Jeruss specializes in the care of patients at high for the development of breast cancer and patients with benign and malignant breast disease.
Dr. Jeruss' clinical and basic research interests are focused on novel therapeutics for aggressive breast cancer subtypes, new approaches to manage cancer metastasis, incorporation of fertility preservation into the care of young patients with cancer, and surgical ethics. Her research efforts, to date, have yielded new insights into the mechanisms associated with breast cancer cell cycle deregulation, implementation of bioengineered scaffolds to forestall breast cancer metastasis, and the basic and clinical translation of fertility preservation for young patients with cancer.
Her research program is funded by the National Institute of Health and several foundations including the Society of Surgical Oncology and A Sister's Hope. She was the recipient of the Society of Surgical Oncology Clinical Investigator Award in Breast Cancer Research that supported the preclinical work for a study directed toward the treatment of patients with hormone receptor negative breast cancer.
For Additional Information